NCT00301925 2018-08-08
TACT2
Institute of Cancer Research, United Kingdom
Phase 3 Unknown
Clinical Trials
6 trialsNCT03404752 2018-01-19
Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.
Gema Biotech S.A.
Phase 3 Unknown
NCT00436709 2014-01-06
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00030758 2013-08-07
Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer
National Cancer Institute (NCI)
Phase 4 Unknown
NCT00516425 2013-08-07
Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00777673 2013-01-04
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
University of Tennessee Cancer Institute
Phase 2 Unknown